Full-Time

Manufacturing Science & Technology: Senior Analytical Transfer Specialist

Posted on 4/4/2023

Cellares

Cellares

51-200 employees

Automated cell therapy manufacturing and development platform

Data & Analytics
Hardware

Senior

San Bruno, CA, USA

Requirements
  • Bachelor's degree in science, engineering, or related field required
  • Knowledge of QC principles, concepts, industry practices, and standards
  • Knowledge of and experience in relevant cell therapy characterization analytical methods including flow cytometry, ELISA, cell based assays, qPCR and ddPCR
  • Exposure to one or more advanced potency methods, such as cytotoxicity or cytokine characterization
  • Understanding of analytical transfer, qualification, and validation, and statistical methods
  • Experience writing, reviewing and approving GMP documentation
  • Understanding of cGMP and regulations/guidance, can interpret guidance documents and make technical recommendations. (QbD, ICH Validation of analytical procedures, FDA regulations)
  • Excellent oral and written communication skills to effectively communicate with internal/external stakeholders, and to author technical documents (protocols, reports, SOP's, investigations, deviations, CAPAs, regulatory filings)
  • Creative, self-motivated, flexible to work in a small company environment and assume a wide variety of tasks
  • Desire to be part of a rapidly evolving organization, with a compelling technology, and taking products and processes to the next level
  • Self-motivated and passionate about advancing the field of cell therapy
  • Excellent planning, organization, technical writing, and time-management skills including the ability to support, problem-solve, and prioritize multiple projects and deadlines
  • Self-awareness, integrity, authenticity, and a growth mindset
Responsibilities
  • Lead the transfer of cell therapy analytical methods to QC from internal Cellares AD or directly from customers
  • Evaluate analytical methods for feasibility, method improvement, remediation, and/or troubleshooting
  • Support analytical method transfer and trending with statistical analysis
  • Responsible for the authoring, review, approval, and oversight of analytical method procedures, method development reports, method validation, training/transfer protocols and reports for internal and external analytical methods
  • Contribute to authoring of regulatory submissions
  • Leads continuous cGMP analytical improvement projects. This includes, but may not be limited to, constant state of validation, improvement of methods and sustaining compliance with global requirements
  • Work as the MSAT Analytical Transfer representative on client projects
  • Prepare and present data associated with QC processes to internal and external clients
  • Define and provide user requirements for QC equipment for the testing of manufactured cell therapies
  • Work with our software team on integration solutions for the QC process and data management, including MES, QMS, and LIMS
  • Provide technical leadership to QC and other departments associated with GMP QC operations
  • Accountable to comply with GxP regulations, guidelines, procedures, and practices governing analytical methods for release and stability testing. Collaborate with internal and external groups cross-functionally as a subject matter expert to ensure compliance, OOS/OOE/OOT investigations, deviations, change controls and CAPAs
  • Provide input when troubleshooting processes on the QC floor
  • Additional duties as assigned
Desired Qualifications
  • 4+ years experience in biologics/gene therapy with a primary focus on analytical method testing and/or transfer for cell therapy products. CDMO experience is a plus

Cellares, as the pioneering Integrated Development and Manufacturing Organization (IDMO), is reshaping the cell therapy manufacturing industry with its unique Industry 4.0 approach, integrating all necessary technologies into a single, high-throughput platform called the Cell Shuttle. This end-to-end automation system not only accelerates drug development and manufacturing but also significantly reduces process failure rates and manufacturing costs. With its strategically located Smart Factories and a robust financial backing of over $355 million, Cellares is well-positioned to meet global patient demand for cell therapies, offering potential partners a competitive edge in the rapidly evolving cell therapy market.

Company Stage

Series C

Total Funding

$373M

Headquarters

South San Francisco, California

Founded

2019

Growth & Insights
Headcount

6 month growth

15%

1 year growth

55%

2 year growth

90%
INACTIVE